L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
eNrtWEtz2jAQvvMrGO6yzSOBdAyZliYtM82UkjDt9JIR1hpEheToYUh/fWWbNKRjmsZEzSUXxujx7Wq1++2uwtPNitVTkIoK3m80vaBRBx4JQvm835henaNe43RQC5c4xTvLul7gNVuNesSwUv1GNuvNAHPlfbv49B7sfpCNQa0eitkSIv1gndGUeR+xWlzgJFtTD1NBSX0FeiFIv5EYnY/WQ6Wl1WKwFvKHSnAEob8d2Z1dXnd2x0M/A/sHVKNAfsJ8Xgoay0qYkZESuB5iDXMhb/fo266ETdUElDAygjHWi7EUKSVAyrXHTEElIfGaXIJMGehMSCm4v4xWqhI4XuLNBG5G5Uq/tbNDvdEoQM1utxccd1rdoNfpVhIld0xVfgv2EH5y3T46CZq9Ez+WPoGIZs6NeCtoHaEgaB/5JPIVqARSRAw6RjGkkoJE+QI7EgnGYA6IAGIYLbDRgOyPkFTngwpz+5EIqe0HwkQkOhOQLUc4pQpRrqk2DFCKo4hyZJfRuaRJghmCmBlgBCMtbVjRYqf568pcJIqFXAG6MZhImmIGmQ4YGQ7bGX0/TCxypro1SuayNNe6kIBzgZHgWuany4Vl+FQJzq0VoKIXjzNzMEf+S9XwYQg6kiPh5tE4IVQlDN96S5VUNRWW2E6DtETp7iDZCa4yH2PWZn/gc8OY/0Stp1tidaRxxttDYaxflvPr+aSqIYbW2WGz/0arpQS92foiBfV8sD8FL0+HYzNjNKpK/paeDSg9nYz2c/8rbb4Ebb7DCqbSHW9+pZyItXp+Pt71f0fa567CykGj61av2+kdtyuTzXcbantqljMjRQK+5WmqDqHfEY/FocRro7cc6i52X8P2v4dt3mOIyMrf02WgitnKxutdU+SMEdyxTTFRCvrh7KpqIH0xIG8v87+l0JT0f4dAtVTuoj6wYbtX8aeTQMGETvpPI8sZdqF1ot74/nq99hZYFTTgWYp5rRVeqlbYKWTdvRM4qZaL7qHIuI5UnxWF1NN8uSonPVZPH9ojbvdve9FSGVoaOOAuivTlLMmMzp4/b903iM7UHj/gWXdi8mYu5wlXpbOZlSIelintvfJzaQnicxzTPe+2e/0y9Is340Et9LP34kHtF/Fonbc=
Mejwh20t731rtn46
